Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Alzheimers Dis ; 32(4): 895-903, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22886021

RESUMEN

Although nutrients or agents with antioxidant properties were reported to show a preventive effect on cognitive decline in animal studies, epidemiologic data on select antioxidants have shown conflicting results. We investigated whether a combination of antioxidants from supplements is effective for the improvement of cognitive function of elderly. Forty-one subjects from a community dwelling aged 65 years and older took supplements containing n-3 polyunsaturated fatty acids (n-3 PUFA), lycopene, and Ginkgo biloba extracts (GE) daily for 3 years. The data of 622 subjects without supplement intake were used as control. We investigated the changes in cognitive function during a 3-year follow-up. We also investigated the influence of apolipoprotein E (APOE) genotype on the effect of antioxidants. We found that a combination of antioxidants improved cognitive function of aged persons after 3 years. Our present study also indicated this improvement in cognitive function with supplement intake in both APOE4 non-carrier (E4-) and APOE4 carrier (E4+) groups. Especially, in E4+, we found a large effect size of the improvement of cognition. When multiple antioxidants are used in combination, they protect against vulnerability to other agents and synergistically potentiate their antioxidant properties. These synergistically potentiated antioxidant effects of agents contribute to the improvement of cognitive function.


Asunto(s)
Antioxidantes/administración & dosificación , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos del Conocimiento/psicología , Cognición/efectos de los fármacos , Suplementos Dietéticos , Anciano , Apolipoproteína E4/genética , Cognición/fisiología , Trastornos del Conocimiento/genética , Quimioterapia Combinada , Ácidos Grasos Omega-3/administración & dosificación , Femenino , Estudios de Seguimiento , Humanos , Masculino
2.
Dement Geriatr Cogn Disord ; 21(1): 16-21, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16254426

RESUMEN

UNLABELLED: To investigate the association between delusions and cerebral functional deficits in Alzheimer's disease (AD), we evaluated probable AD patients with and without delusions. METHODS: Functional brain imaging was performed by single photon emission computed tomography with technetium-99m-labeled ethyl cysteinate dimer (99mTc-ECD) in 64 AD patients and 76 age-matched normal healthy volunteers. SPECT data were analyzed by statistical parametric mapping. RESULTS: In AD patients, no differences were found in age and cognitive activities between those with (n = 25) and without (n = 39) delusions. Compared with normal healthy volunteers, AD patients had significantly decreased perfusion in the posterior cingulate gyri, precunei, and parietal association cortex. Moreover, in the patients with delusions, perfusion was significantly decreased in the frontal lobe with right side dominance. In the comparison between the patients with and without delusions, the patients with delusions had significantly decreased perfusion in the prefrontal cortex, anterior cingulate gyri, inferior to middle temporal cortices, and parietal cortex of the right hemisphere (p < 0.01). CONCLUSION: The functional deficits in the right hemisphere may be the cause of delusions in AD.


Asunto(s)
Enfermedad de Alzheimer/diagnóstico por imagen , Encéfalo/irrigación sanguínea , Tomografía Computarizada de Emisión de Fotón Único , Anciano , Enfermedad de Alzheimer/fisiopatología , Cisteína/análogos & derivados , Deluciones/diagnóstico por imagen , Deluciones/fisiopatología , Humanos , Compuestos de Organotecnecio , Valores de Referencia , Flujo Sanguíneo Regional/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA